カテゴリ： GlobalData, フランス, 企業調査

Enterome Bioscience SA：企業の製品パイプライン分析2018

◆英語タイトル：Enterome Bioscience SA - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C5272
◆発行会社（調査会社）：GlobalData
◆発行日：2018年9月
◆ページ数：38
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome-based biomarkers and screen for microbiome-derived molecules. It also develops new diagnostic products for patient classification and forecasting treatment response. Enterome provides microbiome-derived molecules as drug candidates. The company develops drugs for treatment of microbiome-related diseases which include metabolic, inflammatory bowel diseases, and central nervous system linked diseases. Enterome is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Enterome Bioscience SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Enterome Bioscience SA Company Overview 5
Enterome Bioscience SA Company Snapshot 5
Enterome Bioscience SA Pipeline Products and Ongoing Clinical Trials Overview 5
Enterome Bioscience SA – Pipeline Analysis Overview 8
Enterome Bioscience SA – Key Facts 8
Enterome Bioscience SA – Major Products and Services 9
Enterome Bioscience SA Pipeline Products by Development Stage 10
Enterome Bioscience SA Pipeline Products Overview 12
Biomarker Panel – Liver Cirrhosis 12
Biomarker Panel – Liver Cirrhosis Product Overview 12
Biomarker Test – Non-Alcoholic Fatty Liver Disease (NAFLD) 13
Biomarker Test – Non-Alcoholic Fatty Liver Disease (NAFLD) Product Overview 13
CDx Test (IBD 210) Crohn’s Disease- AIEC Carriage 14
CDx Test (IBD 210) Crohn’s Disease- AIEC Carriage Product Overview 14
Diagnostic Test – Autism 15
Diagnostic Test – Autism Product Overview 15
Diagnostic Test – Depression 16
Diagnostic Test – Depression Product Overview 16
Diagnostic Test – Multiple Sclerosis 17
Diagnostic Test – Multiple Sclerosis Product Overview 17
Diagnostic Test – Parkinson’s Disease 18
Diagnostic Test – Parkinson’s Disease Product Overview 18
Diagnostic Test – Type 2 Diabetes 19
Diagnostic Test – Type 2 Diabetes Product Overview 19
Dx test (IBD 110) Crohn’s Disease – Activity Monitoring 20
Dx test (IBD 110) Crohn’s Disease – Activity Monitoring Product Overview 20
EFL Test 21
EFL Test Product Overview 21
IBD 120 Ulcerative Collitis Relapse Prediction Test 22
IBD 120 Ulcerative Collitis Relapse Prediction Test Product Overview 22
IOC520 23
IOC520 Product Overview 23
MET 220 Bariatric Surgery-Outcome Prediction Test 24
MET 220 Bariatric Surgery-Outcome Prediction Test Product Overview 24
MET 230 Stratified Nutrition Test 25
MET 230 Stratified Nutrition Test Product Overview 25
Non-invasive Monitoring Tool – Cancer 26
Non-invasive Monitoring Tool – Cancer Product Overview 26
Enterome Bioscience SA – Key Competitors 27
Enterome Bioscience SA – Key Employees 28
Enterome Bioscience SA – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Enterome Bioscience SA, Recent Developments 30
Sep 20, 2017: Enterome to Move its Research Laboratories to Genopole, France’s First Biocluster 30
Jul 12, 2017: Enterome Appoints Mary Thistle to its Board of Directors 30
Jul 11, 2017: Enterome and Nestle Health Sciences launch new diagnostics company 30
Dec 09, 2016: Enterome announces management changes 31
Nov 03, 2016: Enterome Appoints Christophe Bonny as Chief Scientific Officer 32
May 19, 2016: Enterome Initiates Strategic Expansion With the Opening of US Office in Cambridge, MA 32
Sep 29, 2015: Georges Gemayel Appointed Non-executive Chairman of Enterome 33
Mar 19, 2015: Oral Presentation and Poster at the IHMC congress in Luxembourg 33
Jun 17, 2014: Enterome to participate on panel at BIO2014 entitled: Microbiome Modulators: Opportunities and Challenges to Creating a New Drug Class 33
Apr 24, 2014: Enterome to Chair Panel at Forthcoming Microbiome / Microbiota R&D and Business Collaboration Forum in London, UK 34
Appendix 35
Methodology 35
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Enterome Bioscience SA Pipeline Products and Ongoing Clinical Trials Overview 5
Enterome Bioscience SA Pipeline Products by Equipment Type 6
Enterome Bioscience SA Pipeline Products by Indication 7
Enterome Bioscience SA, Key Facts 8
Enterome Bioscience SA, Major Products and Services 9
Enterome Bioscience SA Number of Pipeline Products by Development Stage 10
Enterome Bioscience SA Pipeline Products Summary by Development Stage 11
Biomarker Panel - Liver Cirrhosis - Product Status 12
Biomarker Panel - Liver Cirrhosis - Product Description 12
Biomarker Test - Non-Alcoholic Fatty Liver Disease (NAFLD) - Product Status 13
Biomarker Test - Non-Alcoholic Fatty Liver Disease (NAFLD) - Product Description 13
CDx Test (IBD 210) Crohn's Disease- AIEC Carriage - Product Status 14
CDx Test (IBD 210) Crohn's Disease- AIEC Carriage - Product Description 14
Diagnostic Test - Autism - Product Status 15
Diagnostic Test - Autism - Product Description 15
Diagnostic Test - Depression - Product Status 16
Diagnostic Test - Depression - Product Description 16
Diagnostic Test - Multiple Sclerosis - Product Status 17
Diagnostic Test - Multiple Sclerosis - Product Description 17
Diagnostic Test - Parkinson's Disease - Product Status 18
Diagnostic Test - Parkinson's Disease - Product Description 18
Diagnostic Test - Type 2 Diabetes - Product Status 19
Diagnostic Test - Type 2 Diabetes - Product Description 19
Dx test (IBD 110) Crohn's Disease - Activity Monitoring - Product Status 20
Dx test (IBD 110) Crohn's Disease - Activity Monitoring - Product Description 20
EFL Test - Product Status 21
EFL Test - Product Description 21
IBD 120 Ulcerative Collitis Relapse Prediction Test - Product Status 22
IBD 120 Ulcerative Collitis Relapse Prediction Test - Product Description 22
IOC520 - Product Status 23
IOC520 - Product Description 23
MET 220 Bariatric Surgery-Outcome Prediction Test - Product Status 24
MET 220 Bariatric Surgery-Outcome Prediction Test - Product Description 24
MET 230 Stratified Nutrition Test - Product Status 25
MET 230 Stratified Nutrition Test - Product Description 25
Non-invasive Monitoring Tool - Cancer - Product Status 26
Non-invasive Monitoring Tool - Cancer - Product Description 26
Enterome Bioscience SA, Key Employees 28
Enterome Bioscience SA, Subsidiaries 29
Glossary 37

List of Figures
Enterome Bioscience SA Pipeline Products by Equipment Type 6
Enterome Bioscience SA Pipeline Products by Development Stage 10

★海外企業調査レポート[Enterome Bioscience SA：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Akebia Therapeutics Inc (AKBA)：企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Santander Private Bank：企業の戦略・SWOT・財務分析
    Santander Private Bank - Strategy, SWOT and Corporate Finance Report Summary Santander Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Seven Seas Cruises S. DE R.L.：企業の戦略・SWOT・財務情報
    Seven Seas Cruises S. DE R.L. - Strategy, SWOT and Corporate Finance Report Summary Seven Seas Cruises S. DE R.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cantargia AB (CANTA)：企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • Encore Capital Group Inc：企業のM&A・事業提携・投資動向
    Encore Capital Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Encore Capital Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • FirstEnergy Corp：企業の発電所・SWOT分析2018
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Curetis NV (CURE)-医療機器分野：企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …
  • Telstra Corporation Ltd (TLS)：企業の財務・戦略的SWOT分析
    Telstra Corporation Ltd (TLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PAREXEL International Corporation：企業の戦略・SWOT・財務分析
    PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report Summary PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Electricite de France SA：企業の発電所・SWOT分析2018
    Electricite de France SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Astaldi S.p.A.：戦略・SWOT・企業財務分析
    Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Southwestern Electric Power Co：発電所・企業SWOT分析
    Southwestern Electric Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • ADT LLC：戦略・SWOT・企業財務分析
    ADT LLC - Strategy, SWOT and Corporate Finance Report Summary ADT LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Aemetis Inc (AMTX)：企業の財務・戦略的SWOT分析
    Summary Aemetis Inc (Aemetis) formerly AE Biofuels Inc is a renewable fuels and biochemicals company that produces advanced fuels and chemicals. The company’s products include biochemicals, renewable fuels, ethanol, ethanol co-products, glycerin, biodiesel, and edible oils, among others. It also pro …
  • Beckman Coulter, Inc.：企業の戦略・SWOT・財務情報
    Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • DEME NV：企業の戦略的SWOT分析
    DEME NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • United Insurance Holdings Corp.：企業の戦略・SWOT・財務情報
    United Insurance Holdings Corp. - Strategy, SWOT and Corporate Finance Report Summary United Insurance Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bengal Energy Ltd (BNG)：企業の財務・戦略的SWOT分析
    Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets in Australia’s Cooper Basin and India’s Cauvery Basin. The company holds interest in Toooko …
  • Viasat Inc
    Viasat Inc - Strategy, SWOT and Corporate Finance Report Summary Viasat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lear Corp (LEA)：企業の財務・戦略的SWOT分析
    Lear Corp (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆